NFG
ZVRA icon

Next Financial Group’s Zevra Therapeutics ZVRA Stock Holding History

Next Financial Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$22K Hold
2,500
– – ﹤0.01% 1851
2021
Q3 		$23K Hold
2,500
– – ﹤0.01% 1752
2021
Q2 		$32K Hold
2,500
– – ﹤0.01% 1578
2021
Q1 		$23K Buy
+2,500
New +$21.8K ﹤0.01% 1594

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Next Financial Group's ZVRA Position: Q4 2021 in Review

Next Financial Group held its Zevra Therapeutics (ZVRA) position steady in Q4 2021 at 2,500 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Next Financial Group first reported a position in ZVRA in Q1 2021 and has held it in 4 quarters since. The position peaked at $32K in Q2 2021. 77 funds tracked by Wall St. Rank hold ZVRA as of Q4 2021.

  • Next Financial Group held 2,500 shares of Zevra Therapeutics worth $22K as of Q4 2021.
  • Next Financial Group left its Zevra Therapeutics share count unchanged in Q4 2021.
  • Zevra Therapeutics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #1851 holding.
  • Next Financial Group first reported a position in Zevra Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • Next Financial Group's Zevra Therapeutics position peaked at $32K in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.